ARTICLE | Clinical News
Viaskin Peanut: Phase III started
December 14, 2015 8:00 AM UTC
DBV began the double-blind, placebo-controlled, international Phase III PEPITES trial to evaluate 250 ug Viaskin Peanut for 12 months in about 330 patients ages 4-11. ...